Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)

Name: Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)
Published: 2017
License: Public Domain

National Cancer Institute (NCI) · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

advanced lymphoma, advanced malignant solid neoplasm, refractory lymphoma, refractory malignant solid neoplasm, refractory multiple myeloma, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)

Related documents